-
Mashup Score: 7
SES AUA 2022 association of family history of prostate cancer and differences in oncologic outcomes for African American and Caucasian men, positive family history of prostate cancer, the impact of family history on prostate cancer outcomes in African American and Caucasian men.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 3SES AUA 2022: Prolonged Opioid Use Following TURBT: Insurance Claims Review of High-Risk Prescribing to Opioid-Naive Patients - 2 year(s) ago
SES AUA 2022 initial post-TURBT opioids, prolonged opioid use following transurethral resection of bladder tumor (TURBT), opioid dependence due to the frequency of surgical procedures.
Source: www.urotoday.comCategories: Latest Headlines, UrologyTweet-
Prolonged opioid use following TURBT: Insurance claims review of high-risk prescribing to opioid-naive patients. Presentation by @UroCroll @emory_urology. #SESAUA2022 written coverage by @zklaassen_md @GACancerCenter on UroToday > https://t.co/AYeRZ4gbed @SES_AUA https://t.co/vpAKGTzuwS
-
-
Mashup Score: 6SES AUA 2022: COVID-19’s Drastic Impact On Adhering Patients To An Active Surveillance Protocol For Prostate Cancer - 2 year(s) ago
SES AUA 2022 the impact of COVID-19 on adhering patients to an active surveillance protocol for prostate cancer, the effects of the COVID-19 pandemic on patients on an active surveillance protocol at the VA.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
#COVID19’s drastic impact on adhering patients to an #ActiveSurveillance protocol for #ProstateCancer. Presented by Christopher Koller, MD @TulaneUrology. #SESAUA2022 coverage by @zklaassen_md @GACancerCenter > https://t.co/5jZj6OpZV5 @SES_AUA @joshua_g_pincus @CalebNatale https://t.co/TFxo0smfIn
-
-
Mashup Score: 1SES AUA 2022: Racial Variation in MRI-Guided Prostate Biopsy Significant Cancer Detection Among Black and White Men - 2 year(s) ago
racial variation in MRI-guided prostate biopsy significant cancer detection among Black and White men, multiparametric 3T prostate MRI, MRI-ultrasound fusion image-guided prostate biopsies.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Racial variation in MRI-guided prostate biopsy significant cancer detection among Black and White men. Presentation by Callan Brownfield, MD @emory_urology. #SESAUA2022 written coverage by @zklaassen_md @GACancerCenter > https://t.co/YQOo60aq9i @SES_AUA https://t.co/z6OqLkDqnK
-
-
Mashup Score: 12
SES AUA 2022 therapy for locally advanced prostate cancer, locally advanced prostate cancer disease recurrence, alter the disease course with intervention locally advanced prostate cancer, cure locally advanced prostate cancer, Prolong survival of locally advanced prostate cancer, Delay time to systemic therapy for locally advanced prostate cancer
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Optimizing therapy for locally advanced #ProstateCancer. @ChapinMD @MDAndersonNews. #SESAUA2022 written coverage by @zklaassen_md @GACancerCenter on UroToday > https://t.co/mJgMnBUqus @SES_AUA https://t.co/0shuAhDmuL
-
-
Mashup Score: 3SES AUA 2022: Gender Disparities in the Clinical Trials and Real-World Utilization of Systemic Therapy in the Management of Urothelial Carcinoma - 2 year(s) ago
SES AUA 2022 gender disparities in the clinical trials and real-world utilization of systemic therapy in the management of urothelial carcinoma, Urothelial carcinoma of the bladder is more common in men than women, women have an increased risk muscle invasive bladder cancer, if gender disparities exist within the clinical trials utilized to guide recommendations from the National Comprehensive…
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
#GenderDisparities in the clinical trials and real-world utilization of systemic therapy in the management of #UrothelialCarcinoma. Presented by Nick Batra, MD @UF_Urology. #SESAUA2022 written coverage by @zklaassen_md @GACancerCenter > https://t.co/sa2kTWJ5wy @SES_AUA https://t.co/4Dfvval5O8
-
-
Mashup Score: 3
2022 Southeastern Section of the AUA metachronous bladder tumors are predictive of upper tract urothelial carcinoma recurrence in patients treated with radical or endoscopic surgery, Patients with metachronous bladder tumors after a nephroureterectomy, Metachronous bladder tumors role in predicting upper tract recurrence of upper tract urothelial carcinoma, metachronous bladder tumors in…
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Are metachronous bladder tumors predictive of upper tract #UrothelialCarcinoma recurrence in patients treated with radical or endoscopic surgery? Presentation by Christian Ericson, MD @MayoUrology. #SESAUA2022 written coverage by @zklaassen_md > https://t.co/ecXYjNYYsB @SES_AUA https://t.co/K9iO97I2BG
-
-
Mashup Score: 2
SES AUA 2022 the association between visibly complete TURBT and pathologic downstaging following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer, Neoadjuvant chemotherapy followed by radical cystectomy for muscle-invasive bladder cancer, oncologic benefit of a visibly complete TURBT prior to neoadjuvant chemotherapy and radical cystectomy, TURBT prior to…
Source: www.urotoday.comCategories: Latest Headlines, UrologyTweet-
Association between visibly complete TURBT and pathologic downstaging following neoadjuvant chemotherapy and radical cystectomy for #MIBC. Presentation by Bryce Baird, MD @MayoClinic. #SESAUA2022 written coverage by @zklaassen_md > https://t.co/GjiQQgL9fB @SES_AUA https://t.co/ttb8CCEb1K
-
-
Mashup Score: 2
SES AUA 2022 intraoperative intravesical mitomycin C during nephroureterectomy for urothelial carcinoma, mitomycin C bladder cancer, single post-operative instillation of intravesical chemotherapy reduces the risk of bladder tumor recurrence within the first year following radical nephroureterectomy. timing of administration of intravesical chemotherapy. A retrospective review of 51…
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Preliminary results of a single-arm phase II trial of intraoperative intravesical mitomycin-C during nephroureterectomy for #UrothelialCarcinoma. Presented by Hiroko Miyagi, MD @UF. #SESAUA2022 written coverage by @zklaassen_md @GACancerCenter > https://t.co/OEie3MgV55 @SES_AUA https://t.co/zR0e8qLloO
-
-
Mashup Score: 1SES AUA 2022: Extramural Venous Invasion: A Novel Magnetic Resonance Imaging Biomarker For Adverse Pathology In Bladder Cancer - 2 year(s) ago
2022 Southeastern Section of the AUA extramural venous invasion as a novel MRI biomarker for adverse pathology in bladder cancer, Extramural venous invasion identified biomarker for adverse pathology studied in bladder cancer, the feasibility of identifying extramural venous invasion in patients with bladder cancer and its utility in detecting adverse pathology.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Extramural venous invasion: a novel magnetic resonance imaging biomarker for adverse pathology in #BladderCancer. Presentation by @allisonfeibus @UFMedicineJax. #SESAUA2022 written coverage by @zklaassen_md @GACancerCenter on UroToday > https://t.co/nKyinuUJs2 @SES_AUA https://t.co/3yRphfs3fw
-
Family history of #ProstateCancer is not independently associated with differences in oncologic outcomes between #AfricanAmerican and #Caucasian men. Presentation by Aaron Bradshaw, MD @wakeurology. #SESAUA2022 written coverage by @zklaassen_md > https://t.co/TS3nVqiX3Z @SES_AUA https://t.co/TlyIrNELsI